Professional Documents
Culture Documents
Heart Failure (CACAPIT)
Heart Failure (CACAPIT)
HEART FAILURE
NDA
HEART FAILURE
Heart failure (HF) is a clinical syndrome resulting from structural or functional cardiac disorders that impair the ability of
the ventricles to fill or eject blood. The term heart failure indicates myocardial disease in which impaired contraction of
the heart (systolic dysfunction) or filling of the heart (diastolic dysfunction) may cause pulmonary or systemic congestion.
RISK FACTORS
MODIFIABLE NON-MODIFIABLE
Smoking Age
Physical inactivity
Being overweight
PATHOPHYSIOLOGY
Regardless of the etiology, the pathophysiology of HF results in similar pathophysiologic changes and clinical
manifestations. Significant myocardial dysfunction usually occurs before the patient experiences signs and symptoms of
HF such as shortness of breath, edema, or fatigue. As HF develops, the body activates neurohormonal compensatory
mechanisms. These mechanisms represent the body’s attempt to cope with the HF and are responsible for the signs and
symptoms that eventually develop (Porth, 2011). Understanding these mechanisms is important because the treatment for
HF is aimed at opposing them and relieving symptoms.
LEFT SIDED HEART FAILURE
Left-sided heart failure is caused by systolic or pumping dysfunction and this is typically due to some kind of damage to the
myocardium or the heart muscle which means it can't contract as forcefully and pump blood as efficiently. Pulmonary congestion
occurs when the left ventricle cannot effectively pump blood out of the ventricle into the aorta and the systemic circulation. The
increased left ventricular end-diastolic blood volume increases the left ventricular end-diastolic pressure, which decreases blood flow
from the left atrium into the left ventricle during diastole. The blood volume and pressure build up in the left atrium, decreasing flow
through the pulmonary veins into the left atrium. Pulmonary venous blood volume and pressure increase in the lungs, forcing fluid
from the pulmonary capillaries into the pulmonary tissues and alveoli, causing pulmonary interstitial edema and impaired gas
exchange.
Dyspnea
Rales (crackles)
Orthopnea
Weakness
Gaining weight
LAB/ DIAGNOSIS:
Blood tests
BNP
Chest X-ray
Electrocardiogram (ECG)
Stress test
CT scan or MRI
Coronary angiogram
Myocardial biopsy
MEDICAL TREATMENT:
DIGOXIN
DIURETICS
ACE
ARB
LOW DOSE BETA BLOCKERS
VASODILATORS; nitrates, milrinone
Morphine sulfate
Human B natriuretic peptide: acute episodes
NURSING DIAGNOSIS:
NURSING INTERVENTION
LABS/ DIAGNOSIS:
Blood tests
BNP
Chest X-ray
Electrocardiogram (ECG)
Stress test
CT scan or MRI
Coronary angiogram
Myocardial biopsy
MEDICAL TREATMENT
DIGOXIN
DIURETICS
ACE
ARB
LOW DOSE BETA BLOCKERS
VASODILATORS; nitrates, milrinone
Morphine sulfate
Human B natriuretic peptide: acute episodes
NURSING DIAGNOSIS
Activity intolerance related to decreased CO
Excess fluid volume related to the HF syndrome
Anxiety-related symptoms related to complexity of the therapeutic regimem
Powerlessness related to chronic illness and hospitalizations
Ineffective family therapeutic regimen management
NURSING INTERVENTION
Shortness
of breath
Fatigue and
Blood flow and O2 to others
chemoreceptors and symptoms
various tissues of the body
LA= left atrium; LV= left ventricle ; RA= right atrium; RV= right ventricle; RAAS = renin-angiotensin-aldosterone
system